Prostate cancer screening: Contrasting trends - Abstract

PURPOSE: Our previously published data showed rapidly increasing rates of prostate cancer screening in men aged 50-74, which rose from 36 % in 2005 to 48 % in 2008.

Based on men's reported intentions at that time, this was expected to rise to 70 % in 2011. Here we report the actual rate of prostate cancer screening.

METHOD: Three nationwide observational telephone surveys (EDIFICE opinion polls) were conducted in 2005, 2008, and 2011. The overall target was a representative sample of >1,500 individuals living in France and aged 40-75 years, including 481 men aged 50-74 years.

RESULTS: Within this male population, the rate of screening reported remained stable between 2008 and 2011 (48 and 49 %, respectively). However, comparison of privileged versus disadvantaged populations showed significant differences, with a relative decrease in screening among those of higher socioprofessional status (p = 0.03) and from higher-income groups (p = 0.02). For households with a monthly income above 2,500< euro >, the screening rate decreased from 61 % in 2008 to 51 % in 2011 (p = 0.05), while for those with an income below 2,500< euro >, it increased from 36 % in 2008 to 44 % in 2011 (p = 0.18).

CONCLUSION: A plateau or even a reduction in prostate cancer screening is currently being observed; this is possibly due to progressive recognition among the population at large of the controversy surrounding prostate cancer screening, whereas this speculation was formerly limited to health-care professionals. After previously being more likely to undergo prostate cancer screening, it is the younger, wealthier populations that are currently showing the most noteworthy step backwards.

Written by:
Eisinger F, Morère JF, Touboul C, Pivot X, Coscas Y, Blay JY, Lhomel C, Viguier J.   Are you the author?
Paoli-Calmettes Institute, UMR_S912, Marseille, France.  

Reference: Cancer Causes Control. 2015 Mar 31. Epub ahead of print.
doi: 10.1007/s10552-015-0573-9

PubMed Abstract
PMID: 25822574 Prostate Cancer Section